These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25894227)

  • 1. Quantitative analysis of PMLA nanoconjugate components after backbone cleavage.
    Ding H; Patil R; Portilla-Arias J; Black KL; Ljubimova JY; Holler E
    Int J Mol Sci; 2015 Apr; 16(4):8607-20. PubMed ID: 25894227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Combination of Tri-Leucine and Angiopep-2 Drives a Polyanionic Polymalic Acid Nanodrug Platform Across the Blood-Brain Barrier.
    Israel LL; Braubach O; Galstyan A; Chiechi A; Shatalova ES; Grodzinski Z; Ding H; Black KL; Ljubimova JY; Holler E
    ACS Nano; 2019 Feb; 13(2):1253-1271. PubMed ID: 30633492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymalic acid-based nanobiopolymer provides efficient systemic breast cancer treatment by inhibiting both HER2/neu receptor synthesis and activity.
    Inoue S; Ding H; Portilla-Arias J; Hu J; Konda B; Fujita M; Espinoza A; Suhane S; Riley M; Gates M; Patil R; Penichet ML; Ljubimov AV; Black KL; Holler E; Ljubimova JY
    Cancer Res; 2011 Feb; 71(4):1454-64. PubMed ID: 21303974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal Design of Novel Functionalized Nanoconjugates Based on Polymalic Acid for Efficient Tumor Endocytosis with Enhanced Anticancer Activity.
    Guo S; Zhou Q; Yang T; Qiao Y; Fan L; Wang C; Wu H
    J Biomed Nanotechnol; 2018 Jun; 14(6):1039-1051. PubMed ID: 29843869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment.
    Ljubimova JY; Portilla-Arias J; Patil R; Ding H; Inoue S; Markman JL; Rekechenetskiy A; Konda B; Gangalum PR; Chesnokova A; Ljubimov AV; Black KL; Holler E
    J Drug Target; 2013 Dec; 21(10):956-967. PubMed ID: 24032759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of poly(β-L-malic acid)-based charge-conversional nanoconjugates for tumor-specific uptake and cellular delivery.
    Zhou Q; Yang T; Qiao Y; Guo S; Zhu L; Wu H
    Int J Nanomedicine; 2015; 10():1941-52. PubMed ID: 25792828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular delivery of doxorubicin via pH-controlled hydrazone linkage using multifunctional nano vehicle based on poly(β-l-malic acid).
    Patil R; Portilla-Arias J; Ding H; Konda B; Rekechenetskiy A; Inoue S; Black KL; Holler E; Ljubimova JY
    Int J Mol Sci; 2012; 13(9):11681-11693. PubMed ID: 23109877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(malic acid) nanoconjugates containing various antibodies and oligonucleotides for multitargeting drug delivery.
    Ljubimova JY; Fujita M; Ljubimov AV; Torchilin VP; Black KL; Holler E
    Nanomedicine (Lond); 2008 Apr; 3(2):247-65. PubMed ID: 18373429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymalic acid chlorotoxin nanoconjugate for near-infrared fluorescence guided resection of glioblastoma multiforme.
    Patil R; Galstyan A; Sun T; Shatalova ES; Butte P; Mamelak AN; Carico C; Kittle DS; Grodzinski ZB; Chiechi A; Ding H; Black KL; Ljubimova JY; Holler E
    Biomaterials; 2019 Jun; 206():146-159. PubMed ID: 30933776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The optimization of polymalic acid peptide copolymers for endosomolytic drug delivery.
    Ding H; Portilla-Arias J; Patil R; Black KL; Ljubimova JY; Holler E
    Biomaterials; 2011 Aug; 32(22):5269-78. PubMed ID: 21514661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and biological evaluation of a novel pH-sensitive poly (β-malic acid) conjugate for antitumor drug delivery.
    Qiao Y; Liu B; Peng Y; Ji E; Wu H
    Int J Mol Med; 2018 Dec; 42(6):3495-3502. PubMed ID: 30272259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanobiopolymer for direct targeting and inhibition of EGFR expression in triple negative breast cancer.
    Inoue S; Patil R; Portilla-Arias J; Ding H; Konda B; Espinoza A; Mongayt D; Markman JL; Elramsisy A; Phillips HW; Black KL; Holler E; Ljubimova JY
    PLoS One; 2012; 7(2):e31070. PubMed ID: 22355336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymalic acid for translational nanomedicine.
    Huang X; Xu L; Qian H; Wang X; Tao Z
    J Nanobiotechnology; 2022 Jun; 20(1):295. PubMed ID: 35729582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temozolomide delivery to tumor cells by a multifunctional nano vehicle based on poly(β-L-malic acid).
    Patil R; Portilla-Arias J; Ding H; Inoue S; Konda B; Hu J; Wawrowsky KA; Shin PK; Black KL; Holler E; Ljubimova JY
    Pharm Res; 2010 Nov; 27(11):2317-29. PubMed ID: 20387095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of polyelectrolyte complex nanoparticles based on poly (malic acid), chitosan. A pH-dependent delivery system.
    Arif M; Raja MA; Zeenat S; Chi Z; Liu C
    J Biomater Sci Polym Ed; 2017 Jan; 28(1):50-62. PubMed ID: 27691398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albumin-based nanoconjugates for targeted delivery of therapeutic oligonucleotides.
    Ming X; Carver K; Wu L
    Biomaterials; 2013 Oct; 34(32):7939-49. PubMed ID: 23876758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo.
    Khan JA; Kudgus RA; Szabolcs A; Dutta S; Wang E; Cao S; Curran GL; Shah V; Curley S; Mukhopadhyay D; Robertson JD; Bhattacharya R; Mukherjee P
    PLoS One; 2011; 6(6):e20347. PubMed ID: 21738572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymalic acid nanobioconjugate for simultaneous immunostimulation and inhibition of tumor growth in HER2/neu-positive breast cancer.
    Ding H; Helguera G; Rodríguez JA; Markman J; Luria-Pérez R; Gangalum P; Portilla-Arias J; Inoue S; Daniels-Wells TR; Black K; Holler E; Penichet ML; Ljubimova JY
    J Control Release; 2013 Nov; 171(3):322-9. PubMed ID: 23770212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosynthetic Polymalic Acid as a Delivery Nanoplatform for Translational Cancer Medicine.
    Zhang J; Chen D; Liang G; Xu W; Tao Z
    Trends Biochem Sci; 2021 Mar; 46(3):213-224. PubMed ID: 33268216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered borate ester conjugated protein-polymer nanoconjugates for pH-responsive drug delivery.
    Zhou P; Wu S; Hegazy M; Li H; Xu X; Lu H; Huang X
    Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109914. PubMed ID: 31500030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.